Clinical scenario: thalassemia | epistaxis | massive splenomegaly | increase transfusion need
A 9-year-old boy with transfusion-dependent β-thalassemia major has been receiving regular packed red cell transfusions every 3–4 weeks since infancy and is compliant with iron chelation therapy. Over the past year, he has developed progressive abdominal distension and recurrent episodes of epistaxis. Examination reveals massive splenomegaly extending 12 cm below the left costal margin and mild hepatomegaly.
Investigations show:
- Hemoglobin (pre-transfusion): 8.9 g/dL
- White blood cell count: 2.6 × 10⁹/L
- Platelet count: 48 × 10⁹/L
- Reticulocyte count: 3%
- Serum ferritin: 1,600 µg/L
- His annual transfusion requirement has increased by 40% compared with the previous year.
Which of the following is the most appropriate management?
A. Increase transfusion frequency
B. Start corticosteroid therapy
C. Splenectomy
D. Intensify iron chelation
E. Partial splenic artery embolization
correct answer & Explanation:
correct answer :C. Splenectomy
Explanation
This child has hypersplenism secondary to β-thalassemia major, evidenced by:
- Massive splenomegaly
- Thrombocytopenia causing recurrent epistaxis
- Leukopenia
- Increased transfusion requirement (>30–50% increase)
These are accepted indications for splenectomy in transfusion-dependent thalassemia.
Splenectomy reduces:
- Red cell sequestration
- Platelet destruction
- Transfusion requirements
However, it does not cure thalassemia, and transfusions and iron chelation remain necessary.
Before splenectomy, patients should receive:
- Pneumococcal vaccination
- Meningococcal vaccination
- Haemophilus influenzae type b (Hib) vaccination
- Annual influenza vaccination (recommended)
- Lifelong education regarding overwhelming post-splenectomy infection (OPSI)
- Penicillin prophylaxis according to local guidelines
Why the other options are incorrect
A. Increase transfusion frequency
- This does not address hypersplenism and further increases iron loading.
B. Corticosteroids
- The thrombocytopenia is due to splenic sequestration, not immune thrombocytopenia.
D. Increase iron chelation
- Chelation treats iron overload but has no effect on hypersplenism.
E. Partial splenic artery embolization
- It is not standard therapy for hypersplenism in children with thalassemia and is reserved for selected situations.
High-yield Pearls (MRCPCH/FCPS)
- Indications for splenectomy in transfusion-dependent thalassemia:
- Hypersplenism causing cytopenias
- Progressive massive splenomegaly
- Increased transfusion requirement (typically >30–50% above baseline)
- Symptomatic splenic enlargement (pain, early satiety)
- Do not perform elective splenectomy before 5 years of age because of the markedly increased risk of overwhelming post-splenectomy sepsis.
- The common examination trap: Epistaxis in a child with thalassemia and massive splenomegaly is often due to hypersplenism-induced thrombocytopenia, making splenectomy the definitive management rather than platelet transfusions or steroids.
